SCHEDULE 13D/A: P3 Health Partners: Major Shareholder Group Updates Beneficial Ownership Following Financing and Reverse Stock Split

An amendment to a Schedule 13D filing reveals updated beneficial ownership stakes in P3 Health Partners Inc. by Chicago Pacific Founders entities, reflecting a recent financing transaction and a 1-for-50 reverse stock split.

Summary

• Chicago Pacific Founders UGP, LLC and Chicago Pacific Founders GP, L.P. collectively beneficially own 2,208,306 shares of Class A Common Stock, representing 28.33% of the class.
• Chicago Pacific Founders UGP III, LLC and Chicago Pacific Founders GP III, L.P. collectively beneficially own 6,210,082 shares, representing 49.99% of the class, which includes shares issuable from warrants.
• The reported share numbers reflect a 1-for-50 reverse stock split effected by P3 Health Partners Inc. on April 11, 2025.
• P3 Health Group, LLC, a subsidiary of the Company, entered into a financing transaction with VBC Growth SPV 4, LLC on February 13, 2025.
• This financing included an unsecured promissory note and warrants to purchase up to 1,428,129 shares of Class A Common Stock.
• Shareholder approval for the shares underlying these warrants was obtained on June 4, 2025.
• As of May 1, 2025, there were 3,268,093 shares of Class A Common Stock and 3,919,924 shares of Class V Common Stock outstanding.
• Class V Common Stock is redeemable for Class A Common Stock on a 1-for-1 basis, subject to restrictions, and both classes vote as a single class.

Sentiment

Score: 5

Explanation: The document is a factual disclosure of beneficial ownership changes and a financing transaction, with no explicit positive or negative commentary on company performance or outlook. The sentiment is neutral as it primarily serves a compliance purpose.

Positives

• Shareholder approval was obtained for the shares underlying the warrants issued to VBC Growth SPV 4, LLC, completing a key step in the financing transaction.

Future Outlook

The document does not provide forward-looking statements or guidance regarding the company's future financial performance or strategic direction, focusing instead on beneficial ownership changes and a completed financing event.

Industry Context

This filing is a routine disclosure of beneficial ownership changes and a financing event, which does not provide broader industry trend analysis. It reflects a specific capital structure adjustment and investor relationship for P3 Health Partners Inc.

Related Party Transactions

• The financing transaction on February 13, 2025, involved P3 Health Group, LLC (a subsidiary of the Issuer) and VBC Growth SPV 4, LLC.
• The manager of VBC Growth SPV 4, LLC is Founders GP III, which is an affiliate of the principal stockholder of P3 Health Partners Inc.

Stakeholder Impact

• Shareholders: The filing details significant beneficial ownership stakes by Chicago Pacific Founders entities and the issuance of warrants, which could impact the ownership structure and potentially future dilution, although the underlying shares for warrants have received shareholder approval.
• Creditors: The unsecured promissory note issued as part of the financing transaction affects the company's debt structure.

Key Dates

Keywords

P3 Health Partners, Schedule 13D, Beneficial Ownership, Chicago Pacific Founders, Warrants, Reverse Stock Split, Financing Transaction, SEC Filing, Class A Common Stock, Class V Common Stock